These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
310 related articles for article (PubMed ID: 26680539)
21. Beta-N-acetylglucosamine (O-GlcNAc) is part of the histone code. Sakabe K; Wang Z; Hart GW Proc Natl Acad Sci U S A; 2010 Nov; 107(46):19915-20. PubMed ID: 21045127 [TBL] [Abstract][Full Text] [Related]
22. Enhanced transfer of a photocross-linking N-acetylglucosamine (GlcNAc) analog by an O-GlcNAc transferase mutant with converted substrate specificity. Rodriguez AC; Yu SH; Li B; Zegzouti H; Kohler JJ J Biol Chem; 2015 Sep; 290(37):22638-48. PubMed ID: 26240142 [TBL] [Abstract][Full Text] [Related]
23. O-GlcNAcAtlas: A database of experimentally identified O-GlcNAc sites and proteins. Ma J; Li Y; Hou C; Wu C Glycobiology; 2021 Aug; 31(7):719-723. PubMed ID: 33442735 [TBL] [Abstract][Full Text] [Related]
24. Mauri T; Menu-Bouaouiche L; Bardor M; Lefebvre T; Lensink MF; Brysbaert G Adv Appl Bioinform Chem; 2021; 14():87-102. PubMed ID: 34135600 [TBL] [Abstract][Full Text] [Related]
25. Elucidating crosstalk mechanisms between phosphorylation and O-GlcNAcylation. Leney AC; El Atmioui D; Wu W; Ovaa H; Heck AJR Proc Natl Acad Sci U S A; 2017 Aug; 114(35):E7255-E7261. PubMed ID: 28808029 [TBL] [Abstract][Full Text] [Related]
26. O-GlcNAc-specific antibody CTD110.6 cross-reacts with N-GlcNAc2-modified proteins induced under glucose deprivation. Isono T PLoS One; 2011 Apr; 6(4):e18959. PubMed ID: 21526146 [TBL] [Abstract][Full Text] [Related]
27. O-GlcNAc modification affects the ATM-mediated DNA damage response. Miura Y; Sakurai Y; Endo T Biochim Biophys Acta; 2012 Oct; 1820(10):1678-85. PubMed ID: 22759405 [TBL] [Abstract][Full Text] [Related]
28. The conserved threonine-rich region of the HCF-1 Kapuria V; Röhrig UF; Waridel P; Lammers F; Borodkin VS; van Aalten DMF; Zoete V; Herr W J Biol Chem; 2018 Nov; 293(46):17754-17768. PubMed ID: 30224358 [No Abstract] [Full Text] [Related]
29. Comprehensive mapping of O-GlcNAc modification sites using a chemically cleavable tag. Griffin ME; Jensen EH; Mason DE; Jenkins CL; Stone SE; Peters EC; Hsieh-Wilson LC Mol Biosyst; 2016 May; 12(6):1756-9. PubMed ID: 27063346 [TBL] [Abstract][Full Text] [Related]
30. Aspartate Residues Far from the Active Site Drive O-GlcNAc Transferase Substrate Selection. Joiner CM; Levine ZG; Aonbangkhen C; Woo CM; Walker S J Am Chem Soc; 2019 Aug; 141(33):12974-12978. PubMed ID: 31373491 [TBL] [Abstract][Full Text] [Related]
31. Intracellular and extracellular O-linked N-acetylglucosamine in the nervous system. Ogawa M; Sawaguchi S; Kamemura K; Okajima T Exp Neurol; 2015 Dec; 274(Pt B):166-74. PubMed ID: 26278182 [TBL] [Abstract][Full Text] [Related]
32. Swim-exercised mice show a decreased level of protein O-GlcNAcylation and expression of O-GlcNAc transferase in heart. Belke DD J Appl Physiol (1985); 2011 Jul; 111(1):157-62. PubMed ID: 21493720 [TBL] [Abstract][Full Text] [Related]
33. Proteomic analysis of O-GlcNAcylated proteins in invasive ductal breast carcinomas with and without lymph node metastasis. Jiang K; Gao Y; Hou W; Tian F; Ying W; Li L; Bai B; Hou G; Wang PG; Zhang L Amino Acids; 2016 Feb; 48(2):365-74. PubMed ID: 26374642 [TBL] [Abstract][Full Text] [Related]
34. Elevated O-GlcNAcylation promotes gastric cancer cells proliferation by modulating cell cycle related proteins and ERK 1/2 signaling. Jiang M; Qiu Z; Zhang S; Fan X; Cai X; Xu B; Li X; Zhou J; Zhang X; Chu Y; Wang W; Liang J; Horvath T; Yang X; Wu K; Nie Y; Fan D Oncotarget; 2016 Sep; 7(38):61390-61402. PubMed ID: 27542217 [TBL] [Abstract][Full Text] [Related]
35. O-GlcNAc transferase inhibitors: current tools and future challenges. Trapannone R; Rafie K; van Aalten DM Biochem Soc Trans; 2016 Feb; 44(1):88-93. PubMed ID: 26862193 [TBL] [Abstract][Full Text] [Related]
36. O-GlcNAcylation of the Plum pox virus capsid protein catalyzed by SECRET AGENT: characterization of O-GlcNAc sites by electron transfer dissociation mass spectrometry. Kim YC; Udeshi ND; Balsbaugh JL; Shabanowitz J; Hunt DF; Olszewski NE Amino Acids; 2011 Mar; 40(3):869-76. PubMed ID: 20676902 [TBL] [Abstract][Full Text] [Related]
37. Engineering a Proximity-Directed O-GlcNAc Transferase for Selective Protein O-GlcNAcylation in Cells. Ramirez DH; Aonbangkhen C; Wu HY; Naftaly JA; Tang S; O'Meara TR; Woo CM ACS Chem Biol; 2020 Apr; 15(4):1059-1066. PubMed ID: 32119511 [TBL] [Abstract][Full Text] [Related]
38. Decreasing O-GlcNAcylation affects the malignant transformation of MCF-7 cells via Hsp27 expression and its O-GlcNAc modification. Netsirisawan P; Chaiyawat P; Chokchaichamnankit D; Lirdprapamongkol K; Srisomsap C; Svasti J; Champattanachai V Oncol Rep; 2018 Oct; 40(4):2193-2205. PubMed ID: 30106436 [TBL] [Abstract][Full Text] [Related]
39. Polycomb repressive complex 2 is necessary for the normal site-specific O-GlcNAc distribution in mouse embryonic stem cells. Myers SA; Panning B; Burlingame AL Proc Natl Acad Sci U S A; 2011 Jun; 108(23):9490-5. PubMed ID: 21606357 [TBL] [Abstract][Full Text] [Related]
40. Global identification and characterization of both O-GlcNAcylation and phosphorylation at the murine synapse. Trinidad JC; Barkan DT; Gulledge BF; Thalhammer A; Sali A; Schoepfer R; Burlingame AL Mol Cell Proteomics; 2012 Aug; 11(8):215-29. PubMed ID: 22645316 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]